Index of reports
> Disability (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Amerge (Naratriptan) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Amerge side effects in female
Reported by a consumer/non-health professional from France on 2012-05-24
Patient: female
Reactions: Disseminated Intravascular Coagulation, Hepatic Failure, Lactic Acidosis, Gastrointestinal Necrosis, Multi-Organ Failure, Overdose, C-Reactive Protein Increased, Dialysis, Drug Administration Error, Candidiasis, White Blood Cell Count Increased, Intestinal Ischaemia, Neutrophil Count Increased, Intestinal Obstruction, Toxicity To Various Agents, Ascites, Anxiety, Volvulus, Renal Failure, Faecal Vomiting, Septic Shock, Abdominal Adhesions
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Grapefruit Juice (Formulation Unknown) (Grapfruit Juice)
Dosage: see dosage text / oral
Administration route: Oral
Amerge
Dosage: 1 tablet / six times per day / oral
Administration route: Oral
Indication: Migraine
Start date: 2011-04-21
End date: 2011-04-21
Other drugs received by patient: Levothyroxine Sodium; Ibuprofen
|